Abstract
Purpose To elucidate the radiosensitizing effect and underlying mechanism of a new kind of DNA methyltransferase (DNMT) inhibitor with biological availability. Methods A novel non-nucleoside compound, designated as MA-17, was recently derived from a phthalimido alkanamide structure. DNMT expressions were confirmed in cultured human lung cancer (A549) and normal astrocyte (NHA) cells, radiosensitivity was measured using clonogenic assay, and assays of cell cycle alteration, apoptosis, DNA damage repair, and differential gene expression were undertaken. Results MA-17 significantly radiosensitized A549 cells with a mean dose enhancement ratio (DER) of 1.43 at the surviving fraction of 0.2 (p < 0.05 by one-tailed ratio paired t-test). MA-17 did not affect normal astrocytes (mean DER0.2, 1.016; p = 0.420). MA-17 demonstrated a mean half-life of 1.0 h in vivo and a relatively even distribution in various tissues. Pretreatment with MA-17 increased sub-G1 fractions and inhibited the repair of DNA double-strand breaks, which are induced by irradiation. We found that MA-17 also down-regulated DNA homologous recombination and the Fanconi anemia pathway (FANCA, BRCA1, and RAD51C) in A549 cells. This bioinformatics finding was confirmed in ...Continue Reading
References
Feb 1, 1976·AJR. American Journal of Roentgenology·T C LoH Vermund
Dec 1, 1975·Cancer·V VongtamaJ H Webster
Apr 15, 1999·The New England Journal of Medicine·H M KeysD Gersell
Dec 11, 1999·Nucleic Acids Research·M Kanehisa, S Goto
Jan 5, 2002·Acta Oncologica·R A Gatti
Mar 22, 2002·The Lancet Oncology·J Jassem
Jun 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hideaki DotePhilip J Tofilon
Jul 5, 2005·The Lancet Oncology·Kevin M PriseKathryn D Held
Jan 3, 2007·Nature Cell Biology·Bryan M Turner
Feb 27, 2007·Cell·Peter A Jones, Stephen B Baylin
Aug 3, 2007·Nature·Stephen B Baylin, Kornel E Schuebel
May 17, 2008·Molecular Cancer Therapeutics·José A CasadoJuan A Bueren
Nov 29, 2008·Cancer Science·Hong QiuKosei Hirakawa
Feb 14, 2009·International Journal of Radiation Oncology, Biology, Physics·Harlinde De SchutterSandra Nuyts
May 26, 2009·Nucleic Acids Research·Jing ChenAnil G Jegga
Mar 10, 2011·Nature Medicine·Manuel Rodríguez-Paredes, Manel Esteller
Dec 7, 2011·Drugs·Sang-Hyun SongYung-Jue Bang
Mar 20, 2012·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Chara PapadakiJohn Souglakos
Mar 21, 2012·Radiation Oncology·Hak Jae KimIl Han Kim
May 29, 2012·Gene·Augusto NogueiraRui Medeiros
Aug 25, 2012·Cancer Biotherapy & Radiopharmaceuticals·Li WangJuLun Yang
Oct 20, 2012·International Journal of Radiation Oncology, Biology, Physics·Sun Hyun BaeSang Bum Kim
Nov 10, 2012·Archives of Pharmacal Research·Hak Jae KimBeom Soo Shin
Apr 12, 2013·Frontiers in Genetics·Matt Merrifield, Olga Kovalchuk
May 28, 2014·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Kim M SmitsPhilippe Lambin
Oct 18, 2015·Nucleic Acids Research·Minoru KanehisaMao Tanabe
Dec 15, 2015·Blood·Bas J Wouters, Ruud Delwel
Dec 23, 2015·Clinical Epigenetics·Clara NerviGiovanni Codacci-Pisanelli
Dec 3, 2016·Nucleic Acids Research·Minoru KanehisaKanae Morishima